Delivery Order SPE2DB22D1106-SPE2DB24FEAP1
- Not listed
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,563,606,240 units of Vyvanse 40 mg capsules, with a potential value of $3,138.50. The contract completion date is February 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The order is for the delivery of Vyvanse 40 mg capsules, a brand name medication, worth $1,215.05. The delivery order has a completion date of February 15, 2024 and was awarded on February 14, 2024. This delivery order is placed under an Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The order is for 100 units of the pharmaceutical product Vyvanse 40 mg capsule, with a completion date of March 4, 2024 and a potential value of $2,747.98. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, to supply 4,564,001,383 units of the drug Vyvanse 40 mg capsules. The $1,724.00 order has a completion date of March 19, 2024 and does not utilize a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025 to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4,564,118,788 units of the pharmaceutical product Vyvanse 50 mg capsules. The total ceiling value of the contract is $10,020.09 with a performance period through April 1, 2024. This delivery order falls under a larger...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,787,389 units of 40 mg Vyvanse capsules. The contract has a potential value of $2,038.25 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is issued under a larger indefinite...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,127.76 contract is for the supply of 100 units of the prescription medication Vyvanse 60 mg capsules. The order has an ultimate completion date of April 18, 2025. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4,564,026,397 units of the pharmaceutical product Vyvanse 70 mg capsule. The contract has a ceiling value of $1,776.83 and a performance period through March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Vyvanse 40 mg capsules, a brand name pharmaceutical product, with a ceiling value of $1,054.38 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $4,004.15, is for the supply of Vyvanse 40 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 and running through December 2025. The IDC serves as the primary vehicle for Amerisourcebergen...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEAP1Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 100 units of the drug Vyvanse 60 mg capsules, with a completion date of February 16, 2024 and a potential value of $1,724.00. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide. No set-aside designation was used for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 2/15/24 |